A trivalent recombinant Ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous SIV challenge

It has been suggested that poor immunogenicity may explain the lack of vaccine efficacy in preventing or controlling HIV infection in the Step trial. To investigate this issue we vaccinated eight Indian rhesus macaques with a trivalent replication-incompetent adenovirus serotype 5 vaccine expressing...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Reynolds, Matthew R., Weiler, Andrea M., Piaskowski, Shari M., Piatak, Michael, Robertson, Henry T., Allison, David B., Bett, Andrew J., Casimiro, Danilo R., Shiver, John W., Wilson, Nancy A., Lifson, Jeffrey D., Koff, Wayne C., Watkins, David I.
Format: Artigo
Langue:Inglês
Publié: 2012
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3372643/
https://ncbi.nlm.nih.gov/pubmed/22569124
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2012.04.082
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires